Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Matawan, NJ
SEC filing record 1 source field available
Fiscal year end
31 December
Apimeds Pharmaceuticals US, Inc. has filed 118 SEC EDGAR filings since 29 Jan 2024

SEC filing history

Showing 26-50 of 118 matching filings.

Per page
25
Current page
2
425 File 001-42545

CURRENT REPORT

Filing date
02 Dec 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-42545

CURRENT REPORT

Filing date
02 Dec 2025
Reporting date
01 Dec 2025
Next action
Verify source filing
4/A

PRIMARY DOCUMENT

Filing date
21 Nov 2025
Reporting date
12 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-42545

CURRENT REPORT

Filing date
18 Nov 2025
Reporting date
13 Nov 2025
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
13 Nov 2025
Reporting date
11 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
13 Nov 2025
Reporting date
11 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
13 Nov 2025
Reporting date
11 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
13 Nov 2025
Reporting date
11 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
13 Nov 2025
Reporting date
11 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-42545

QUARTERLY REPORT

Filing date
12 Nov 2025
Reporting date
30 Sep 2025
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
24 Oct 2025
Reporting date
15 Oct 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
21 Oct 2025
Reporting date
15 Oct 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 Oct 2025
Reporting date
15 Oct 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 Oct 2025
Reporting date
15 Oct 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 Oct 2025
Reporting date
15 Oct 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 Oct 2025
Reporting date
15 Oct 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 Oct 2025
Reporting date
15 Oct 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-42545

CURRENT REPORT

Filing date
16 Oct 2025
Reporting date
15 Oct 2025
Next action
Verify source filing
10-Q File 001-42545

QUARTERLY REPORT

Filing date
19 Aug 2025
Reporting date
30 Jun 2025
Next action
Verify source filing
NT 10-Q File 001-42545

NOTIFICATION OF LATE FILING

Filing date
14 Aug 2025
Reporting date
30 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-42545

CURRENT REPORT

Filing date
16 Jul 2025
Reporting date
15 Jul 2025
Next action
Verify source filing
4/A

PRIMARY DOCUMENT

Filing date
11 Jun 2025
Reporting date
12 May 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3/A

PRIMARY DOCUMENT

Filing date
11 Jun 2025
Reporting date
04 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-42545

CURRENT REPORT

Filing date
05 Jun 2025
Reporting date
30 May 2025
Next action
Verify source filing
S-8 File 333-287564

REGISTRATION STATEMENT

Filing date
23 May 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .